IL9 and chronic obstructive pulmonary disease: For example, antibody-mediated neutralization of IL9 has been described to decrease lung inflammation and tissue damages caused by oxidative stress in a murine model of COPD [42] and to suppress lung injury and pulmonary fibrosis in mice that were intranasally exposed to silica [24].